The Anti-Obesity Drugs Market Growing at 39% CAGR to 2019

News provided by

Nov 28, 2014, 06:30 ET

DALLAS, November 28, 2014 /PRNewswire/ --

ReportsnReports.com adds Global Anti-Obesity Drugs Market 2015-2019 research report of 78 pages to the fast growing pharmaceuticals industry intelligence and data collection of its library. According to this research, the global anti-obesity drugs market is set to grow at a CAGR of 39.45% over the period 2014-2019. Complete research is available at http://www.reportsnreports.com/reports/318547-global-anti-obesity-drugs-market-2015-2019.html .

For the anti-obesity drugs market, growing rates of obesity worldwide are offering huge opportunities for drug manufacturing companies to develop and manufacture highly effective drugs. Vendors are expected to gear up for intense competition in the worldwide anti-obesity drugs industry. New pipeline drugs developed by vendors should display efficacy and safety profiles that surpass options currently on the market. The landscape is vast, with competitors ranging from Arena Pharmaceuticals and Orexigen Therapeutics to big pharmaceutical companies, gearing up to make better, more effective anti-obesity drugs with fewer side effects. Anti-obesity drugs currently available on the market come with a list of troubling side effects. Any product offerings that are safe for long-term use will likely have a positive impact on market growth through to 2019.

The Global Anti-obesity Drugs market is divided into two segments: Peripherally Acting Anti-obesity Drugs and Centrally Acting Anti-obesity Drugs. This report covers the present scenario and the growth prospects of the Global Anti-obesity Drugs market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of FDA approved drugs and OTC medications used in the treatment of obesity that are available in the market.

Anti-Obesity drug companies like Arena Pharmaceuticals, F. Hoffmann-La Roche, GlaxoSmithKline, Orexigen Therapeutics, Vivus, Amylin, Alizyme, Boehringer Ingelheim, Eisai, Merck, Norgine, Novo Nordisk, Pfizer, Rhythm Pharmaceuticals, Shionogi USA, Takeda Pharmaceutical and Zafgan are discussed in this research available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=318547 .

The Global Anti-obesity Drugs Market 2015-2019 report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Anti-obesity Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key questions on the anti-obesity drugs sector like what will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? are answered through this research.

20 data exhibits provided in this worldwide anti-obesity drugs market research include:

Market Research Methodology
Global Anti-obesity Drugs Market 2013-2018 (US$ million)
US Prevalence of Adult Overweight and Obesity (NHANES 2011-2012)
US Prevalence of Childhood Overweight and Obesity (NHANES 2011-2012)
Types of Obesity
Causes of Obesity
Global Anti-obesity Drugs Market Segmentation by Drug Class
Global Anti-obesity Drugs Market by Geographical Segmentation 2014
Arena Pharmaceuticals: Geographical Segmentation
F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
GlaxoSmithKline: Business Segmentation 2013
GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
GlaxoSmithKline: Sales by Geography 2013
GlaxoSmithKline: Pipeline Products 2013
Vivus: Business Segmentation by Revenue 2013
Vivus: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Vivus: Geographical Segmentation by Revenue 2013

On a relevant topic, the Weight Loss/Obesity Management Market - [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, Stomaphyx] - Global Forecasts To 2017 research report says worldwide weight loss/obesity management market is expected to reach $361 billion by 2017. Low calorie beverages (carbonated and non-carbonated), and slimmer waters/natural mineral salt drinks showcase vast opportunities for key players in this market. Herbal/green market is also growing at a very fast pace in Asian countries, especially in China. The Asian market, especially India and China, is expected to witness a boost in demand for weight loss products, and is poised to register maximum growth over the next five years, owing to the rising obesity rates and related health problems. Atkins Nutritionals, Inc. (U.S.), Weight Watchers International, Inc. (U.S.), NutriSystem, Inc. (U.S.), Herbalife International, Inc. (U.S.), The Coca Cola Company (U.S.), and PepsiCo, Inc. (U.S.) are the leading global players in the weight loss diet market, while the weight loss services market is lead by Equinox, Inc. (U.S.), Life Time Fitness, Inc. (U.S.), Golds Gym International, Inc. (U.S.), Weight Watchers International, Inc. (U.S.), and eDiets.com (U.S.) Brunswick Corporation (U.S.), Fitness First (U.K.), Precor, Inc. (U.S.), ICON Health &; Fitness, Inc. (U.S.), LifeCORE Fitness, Inc. (U.S.), and Johnson Health Tech. Co., Ltd (Taiwan) are leading players in the weight loss fitness equipment market. Ethicon Endo-surgery, Inc. (U.S.), Cynosure, Inc. (U.S.), and Allergan, Inc. (U.S.) are eminent players in the global weight loss surgical equipment market. Comprehensive table of contents and more on this research is available at http://www.reportsnreports.com/reports/247344-weight-loss-obesity-management-market-meal-replacements-slimming-centers-nutrition-psychological-consultancy-treadmill-ellipticals-strength-training-gastric-bypass-intragastric-balloon-system-stomaphyx-global-forecasts-to-2017.html .

Explore more reports by Infiniti Research Ltd at http://www.reportsnreports.com/publisher/infiniti-research-limited/ and by MarketsandMarkets at http://www.reportsnreports.com/publisher/marketsandmarkets/ .

About Us:

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
[email protected]

Connect With Us on:

Facebook: https: //www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: www.linkedin.com/company/reportsnreports

Twitter: https: //twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

Pinterest: www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds: http: //www.reportsnreports.com/feed/l-latestreports.xml

SOURCE ReportsnReports